Viyash Scientific: Update on Incorporation of step down wholly owned Subsidiary in vietnam
Viyash Scientific (VIYASH) filed a disclosure titled "Update on Incorporation of step down wholly owned Subsidiary in vietnam". The company is valued at about ₹9,625 crore.
What happened
Viyash Scientific (VIYASH) filed a disclosure with the exchanges on 2 November 2026 at 05:35 PM titled "Update on Incorporation of step down wholly owned Subsidiary in vietnam".
Company snapshot
Viyash Scientific is a small-cap company in the Healthcare sector, with a market value of about ₹9,625 crore.
The stock last traded at ₹220.3, against a 52-week range of ₹178.1–₹298 (26.1% below the high).
Before this filing the shares had moved −7.4% over the month and −17.2% over three months. Average daily turnover over the last 20 sessions was about ₹49.62 crore.
Promoters held 61.31% at the end of Q1 FY27. Foreign institutions owned 4.50% and domestic institutions 3.75%.
| Quarter | Revenue | Net profit | EPS (₹) |
|---|---|---|---|
| Q1 FY26 | 441 | 14.3 | 0.57 |
| Q2 FY26 | 424 | 14.7 | 0.59 |
| Q3 FY26 | 858 | 38.4 | 0.89 |
| Q4 FY26 | 920 | 52.1 | 1.2 |
| Q1 FY27 | 946 | 65.9 | 1.51 |
What history shows
This is not the company's first m&a disclosure: BCEIE has 3 earlier filings of this kind on record since May 2026.
After those filings, the stock fell 0.3% on average the next trading day and was down 5.5% on average after five days (3 filings with price data).
Across 152 similar disclosures by other Healthcare companies, shares moved +0.8% on average the next day and +0.9% over five days; 58% of them rose the next day.
Market-wide, 2,237 m&a filings with an impact score of 50 or more saw an average next-day move of +0.3%, with 49% rising.
Past reactions describe what happened before; they are not a forecast.
| Date | Filing | Next day | 5 days |
|---|---|---|---|
| 1 Oct 2026 | Completion of acquisition of BioForLife Italia S.r.l. | −1.2% | — |
| 8 Sept 2026 | Update on proposed acquisition of BioForLife Italia S.r.l | −0.6% | −8.8% |
| 8 Jun 2026 | M&A | +0.8% | −2.1% |
What to watch
- Regulatory approvals, completion of the deal and its effect on revenue and margins.
In the news
Recent coverage elsewhere (links open the original publisher):
- Viyash Scientific appoints Dr. Nagineni as SVP HR amid leadership change
- Viyash Scientific Limited Estimates – NSE:VIYASH
- Viyash Scientific (NSE:VIYASH): Why Did It Publish a Special Window Notice for Physical Securities?
- Zee Business. . चार्ट चालीसा आज Viyash Scientific के चार्ट पर नजर! Bullish Engulfing Pattern से कितनी तेजी के संकेत? चार्ट पर ब्रेकआउट या ब्रेकडाउन? कुणाल सरावगी से जानें चार्ट पैटर्न #ChartChalisa #T
- Viyash Scientific appoints Dr. Mallikharjuna Rao Nagineni as Senior Vice President, Human Resources
Source
Automatically written from the exchange filing and BCEIE data. Not investment advice. Check the original filing before acting on it.